Inovalon Holdings, Inc. (INOV) President Robert A. Wychulis Sells 85,828 Shares
Inovalon Holdings, Inc. (NASDAQ:INOV) President Robert A. Wychulis sold 85,828 shares of the business’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $15.54, for a total value of $1,333,767.12. Following the completion of the sale, the president now owns 466,286 shares of the company’s stock, valued at $7,246,084.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Inovalon Holdings, Inc. (NASDAQ:INOV) traded up $0.10 during midday trading on Wednesday, reaching $15.30. The company’s stock had a trading volume of 409,600 shares, compared to its average volume of 567,830. The company has a quick ratio of 5.62, a current ratio of 5.62 and a debt-to-equity ratio of 0.31. Inovalon Holdings, Inc. has a 12-month low of $8.60 and a 12-month high of $17.80. The company has a market capitalization of $2,217.25, a PE ratio of 72.38, a PEG ratio of 4.45 and a beta of 1.24.
Inovalon (NASDAQ:INOV) last released its earnings results on Wednesday, November 1st. The technology company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.01. Inovalon had a return on equity of 4.63% and a net margin of 4.07%. The firm had revenue of $115.90 million during the quarter, compared to analysts’ expectations of $114.79 million. During the same period in the prior year, the company earned $0.10 earnings per share. The company’s quarterly revenue was up 10.4% on a year-over-year basis. equities research analysts expect that Inovalon Holdings, Inc. will post 0.24 earnings per share for the current year.
Several equities research analysts recently issued reports on the company. KeyCorp reiterated a “hold” rating on shares of Inovalon in a research note on Tuesday, September 12th. TheStreet upgraded Inovalon from a “d+” rating to a “c-” rating in a research note on Thursday, October 5th. BidaskClub cut Inovalon from a “hold” rating to a “sell” rating in a research note on Saturday. Zacks Investment Research cut Inovalon from a “hold” rating to a “sell” rating in a research note on Tuesday, November 7th. Finally, Morgan Stanley upgraded Inovalon from an “underweight” rating to an “equal weight” rating and boosted their price target for the company from $9.00 to $14.00 in a research note on Tuesday, September 12th. Three investment analysts have rated the stock with a sell rating and six have assigned a hold rating to the stock. Inovalon presently has a consensus rating of “Hold” and an average price target of $12.00.
ILLEGAL ACTIVITY NOTICE: This story was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/12/06/inovalon-holdings-inc-inov-president-robert-a-wychulis-sells-85828-shares.html.
Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.
Receive News & Ratings for Inovalon Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.